Skip to menu Skip to content Skip to footer

2013

Journal Article

Patients undergoing lymphadenectomy for Stage III melanomas of known or unknown primary site do not differ in outcome

Hughes, Maria Celia, Wright, Annaliesa, Barbour, Andrew, Thomas, Janine, Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2013). Patients undergoing lymphadenectomy for Stage III melanomas of known or unknown primary site do not differ in outcome. International Journal of Cancer, 133 (12), 3000-3007. doi: 10.1002/ijc.28318

Patients undergoing lymphadenectomy for Stage III melanomas of known or unknown primary site do not differ in outcome

2013

Conference Publication

The Volume-Outcome Relationship in Cancer Surgery - Do Rural Patients Have a Choice?

Smithers, Mark, Zarate, Dannie, Harden, Hazel, Colquist, Shoni and Walpole, Euan (2013). The Volume-Outcome Relationship in Cancer Surgery - Do Rural Patients Have a Choice?. HOBOKEN: WILEY-BLACKWELL.

The Volume-Outcome Relationship in Cancer Surgery - Do Rural Patients Have a Choice?

2013

Journal Article

Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy

Pinkham, Mark B., Foote, Matthew C., Burmeister, Elizabeth, Thomas, Janine, Meakin, Janelle, Smithers, B. Mark and Burmeister, Bryan H. (2013). Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy. International Journal of Radiation: Oncology - Biology - Physics, 86 (4), 702-708. doi: 10.1016/j.ijrobp.2013.03.019

Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy

2013

Conference Publication

Australian Multi-Center Study of Isolated Limb Infusion Chemotherapy for Melanoma: Experience Outside of the Sydney Melanoma Unit

Kroon, H., Coventry, B., Giles, M., Henderson, M., Serpell, J. and Smithers, M. (2013). Australian Multi-Center Study of Isolated Limb Infusion Chemotherapy for Melanoma: Experience Outside of the Sydney Melanoma Unit. HOBOKEN: WILEY-BLACKWELL.

Australian Multi-Center Study of Isolated Limb Infusion Chemotherapy for Melanoma: Experience Outside of the Sydney Melanoma Unit

2013

Journal Article

Surgery and the management of cutaneous melanoma

Allan, C. and Smithers, B. M. (2013). Surgery and the management of cutaneous melanoma. British Journal of Surgery, 100 (3), 313-315. doi: 10.1002/bjs.9054

Surgery and the management of cutaneous melanoma

2013

Book Chapter

Esophagus carcinoma surveillance counter: Australia

Smithers, Bernard Mark, Thomas, Janine M. and Burmeister, Bryan H. (2013). Esophagus carcinoma surveillance counter: Australia. Patient Surveillance after Cancer Treatment. (pp. 97-100) edited by Frank Johnson, Yoshihiko Maehara, George P. Browman, Julie A. Margenthaler, Riccardo A. Audisio, John F. Thompson, David Y. Johnson, Craig C. Earle and Katerine S. Virgo. New York, United States: Humana Press. doi: 10.1007/978-1-60327-969-7_17

Esophagus carcinoma surveillance counter: Australia

2013

Conference Publication

Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomas

Rowe, C. J., Rodero, M., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2013). Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomas. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, NSW Australia, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12051

Pilot multi-marker analysis to evaluate prognosis in stage Ib and II melanomas

2013

Conference Publication

Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy of autoimmune disease

Burton, B. R., Britton, G. J., Fang, H., Verhagen, J., Smithers, B., Sabatos-Peyton, C. A., Carney, L. J., Gough, J., Strobel, S. and Wraith, C. (2013). Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy of autoimmune disease. Annual Congress of the British-Society-for-Immunology, Liverpool England, Dec 02-05, 2013. West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/imm.12217

Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy of autoimmune disease

2013

Conference Publication

Survival and recurrence outcome in patients with melanomas of unknown primary invading lymph nodes

Wright, A., Hughes, M., Siskind, V., Smithers, M., Thomas, J., Green, A. and Khosrotehrani, K. (2013). Survival and recurrence outcome in patients with melanomas of unknown primary invading lymph nodes. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, NSW Australia, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/ajd.12051

Survival and recurrence outcome in patients with melanomas of unknown primary invading lymph nodes

2013

Conference Publication

Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01)

Henderson, Michael A., Burmeister, Bryan, Ainslie, Jill, Fisher, Richard, Di Iulio, Julianna, Smithers, Bernard Mark, Hong, Angela, Shannon, Kerwin F., Scolyer, Richard A., Carruthers, Scott, Coventry, Brendon J., Babington, Scott, Duprat, Joao, Hoekstra, Harald J. and Thompson, John F. (2013). Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago IL United States, May 31-Jun 04, 2013. United States: American Society of Clinical Oncology.

Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01)

2013

Journal Article

Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer

Smithers, B. Mark and Thomson, Iain (2013). Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer. Thoracic Surgery Clinics, 23 (4), 509-523. doi: 10.1016/j.thorsurg.2013.07.005

Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer

2013

Conference Publication

Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal

Agarwala, S., Thompson, J. F., Smithers, B. M., Ross, M. I., Coventry, B. J., Minor, D. R., Scoggins, C. R., Singer, J. M. and Wachter, E. A. (2013). Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal. 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam Netherlands, Sep 27-Oct 01, 2013. Oxford United Kingdom: Pergamon. doi: 10.1016/S0959-8049(13)70065-0

Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal

2013

Journal Article

Impact of postoperative morbidity on long-term survival after oesophagectomy

Hii, M. W., Smithers, B. M., Gotley, D. C., Thomas, J. M., Thomson, I., Martin, I. and Barbour, A. P. (2013). Impact of postoperative morbidity on long-term survival after oesophagectomy. British Journal of Surgery, 100 (1), 95-104. doi: 10.1002/bjs.8973

Impact of postoperative morbidity on long-term survival after oesophagectomy

2012

Journal Article

Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community

Pandeya, N., Green, A. C., Whiteman, D. C., The Australian Cancer Study and Smithers, B. M. (2012). Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Diseases of the Esophagus, 25 (7), 573-583. doi: 10.1111/j.1442-2050.2011.01287.x

Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community

2012

Journal Article

Metastasectomy for distant metastatic melanoma: analysis of data from the first multicenter selective lymphadenectomy trial (MSLT-I)

Howard, J. Harrison, Thompson, John F., Mozzillo, Nicola, Nieweg, Omgo E., Hoekstra, Harald J., Roses, Daniel F., Sondak, Vernon K., Reintgen, Douglas S., Kashani-Sabet, Mohammed, Karakousis, Constantine P., Coventry, Brendon J., Kraybill, William G., Smithers, B. Mark, Elashoff, Robert, Stern, Stacey L., Cochran, Alistair J., Faries, Mark B. and Morton, Donald L. (2012). Metastasectomy for distant metastatic melanoma: analysis of data from the first multicenter selective lymphadenectomy trial (MSLT-I). Annals of Surgical Oncology, 19 (8), 2547-2555. doi: 10.1245/s10434-012-2398-z

Metastasectomy for distant metastatic melanoma: analysis of data from the first multicenter selective lymphadenectomy trial (MSLT-I)

2012

Journal Article

Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia

Gordon, Louisa G., Hirst, Nicholas G., Mayne, George C., Watson, David I., Bright, Timothy, Cai, Wang, Barbour, Andrew P., Smithers, Bernard M., Whiteman, David C. and Eckermann, Simon (2012). Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. Journal of Gastrointestinal Surgery, 16 (8), 1451-1461. doi: 10.1007/s11605-012-1911-9

Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia

2012

Journal Article

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial

Burmeister, Bryan H., Henderson, Michael A., Ainslie, Jill, Fisher, Richard, Di Iulio, Juliana, Smithers, B. Mark, Hong, Angela, Shannon, Kerwin, Scolyer, Richard A., Carruthers, Scott, Coventry, Brendon J., Babington, Scott, Duprat, Joao, Hoekstra, Harald J. and Thompson, John F. (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncology, 13 (6), 589-597. doi: 10.1016/S1470-2045(12)70138-9

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial

2012

Journal Article

An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection

Foote, Matthew, Burmeister, Bryan, Dwyer, Patrick, Burmeister, Elizabeth, Lambie, Duncan, Allan, Christopher, Barbour, Andrew, Bayley, Gerard, Pullar, Andrew, Meakin, Janelle, Thomas, Janine and Smithers, Mark (2012). An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection. Melanoma Research, 22 (3), 257-262. doi: 10.1097/CMR.0b013e3283531335

An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection

2012

Conference Publication

TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG)

Leong, Trevor, Smithers, Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Zalcberg, John Raymond, Wong, Rebecca and Haustermans, Karin (2012). TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

TOPGEAR: An international randomized phase III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (AGITG/TROG/EORTC/NCIC CTG)

2012

Journal Article

Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia

Green, Adele C., Baade, Peter, Coory, Michael, Aitken, Joanne F. and Smithers, Mark (2012). Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. Journal of Clinical Oncology, 30 (13), 1462-1467. doi: 10.1200/JCO.2011.38.8561

Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia